POSITIVELY PRECISE.
We’re developing targeted therapies to lower LDL-cholesterol for patients not adequately treated with current lipid-modifying therapies.
Learn More
Pipeline
Esperion is a pharmaceutical company focused on developing and commercializing non-statin, once-daily, oral, LDL-C–lowering therapies for the treatment of patients with hypercholesterolemia.
learn more